Drug Shortage Report for TEVA-OXYCOCET
| Report ID | 253150 |
| Drug Identification Number | 00608165 |
| Brand name | TEVA-OXYCOCET |
| Common or Proper name | TEVA-OXYCOCET TABLETS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN OXYCODONE HYDROCHLORIDE |
| Strength(s) | 325MG 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| Anatomical Therapeutical Chemical (ATC) code | N02AJ |
| Anatomical Therapeutical Chemical (ATC) description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-03-19 |
| Estimated end date | 2026-03-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v63 | 2026-03-12 | French | Compare |
| v62 | 2026-03-12 | English | Compare |
| v61 | 2026-02-12 | French | Compare |
| v60 | 2026-02-12 | English | Compare |
| v59 | 2026-02-05 | French | Compare |
| v58 | 2026-02-05 | English | Compare |
| v57 | 2026-01-29 | French | Compare |
| v56 | 2026-01-29 | English | Compare |
| v55 | 2026-01-22 | French | Compare |
| v54 | 2026-01-22 | English | Compare |
| v53 | 2026-01-15 | French | Compare |
| v52 | 2026-01-15 | English | Compare |
| v51 | 2025-12-18 | French | Compare |
| v50 | 2025-12-18 | English | Compare |
| v49 | 2025-12-15 | French | Compare |
| v48 | 2025-12-15 | English | Compare |
| v47 | 2025-12-05 | French | Compare |
| v46 | 2025-12-05 | English | Compare |
| v45 | 2025-12-04 | French | Compare |
| v44 | 2025-12-04 | English | Compare |